@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HGD6GZ6P-K
  skos:prefLabel "Antihistaminiques des récepteurs H1"@fr, "Histamine H1 Antagonists"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-SLLN8F4V-8
  skos:prefLabel "Anticonvulsants"@en, "Anticonvulsivants"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W8MNH2H7-8
  skos:prefLabel "Inhibiteurs des canaux calciques"@fr, "Calcium Channel Blockers"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-K9FBN5C5-1
  skos:prefLabel "Vasodilator Agents"@en, "Vasodilatateurs"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-ZSFBN4K6-W
  skos:prefLabel "Piperazines"@en, "Pipérazines"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-MC45LQKR-X .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-MC45LQKR-X
  mesh:allowableQualifier jvr:-M63HSDM7-1, jvr:-CB30NGKB-3, jvr:-NFTHND7Q-8, jvr:-NKM836P1-M, jvr:-G30ZJ446-J, jvr:-L6C0XPHT-4, jvr:-H7K65Q8S-Z, jvr:-W6SQV79N-S, jvr:-G4R176S9-J, jvr:-NHL3D2X0-S, jvr:-FWD2BGQ0-9, jvr:-D0F21513-5, jvr:-XV06LPML-W, jvr:-T9HQD7ST-J, jvr:-WK5F724J-1, jvr:-BT300B3G-Q, jvr:-TJHVZCRZ-0, jvr:-NB0XHT3S-N, jvr:-HQRFT0C6-B, jvr:-R3QWLHRG-V, jvr:-R0ZCQ8X6-J, jvr:-THHNVC7V-3, jvr:-S0CS1X5R-5, jvr:-SBNWSM1T-R, jvr:-Q3979798-W ;
  skos:hiddenLabel "Sibelium"@en, "R14950"@fr, "Chlorhydrate de flunarizine"@fr, "R-14950"@fr, "R-14950"@en, "Flunarizine Hydrochloride"@en, "Flunarizine Dihydrochloride"@en ;
  mesh:pharmacologicalAction jvr:-K9FBN5C5-1, jvr:-SLLN8F4V-8, jvr:-W8MNH2H7-8, jvr:-HGD6GZ6P-K ;
  skos:altLabel "Piperazine, 1-(bis(4-fluorophenyl)methyl)-4-(3-phenyl-2-propenyl)-, (E)-"@fr, "Piperazine, 1-(bis(4-fluorophenyl)methyl)-4-(3-phenyl-2-propenyl)-, (E)-"@en, "52468-60-7 (Flunarizine)"@fr, "52468-60-7 (Flunarizine)"@en, "R7PLA2DM0J"@fr, "R7PLA2DM0J"@en, "30484-77-6 (di-HCl)"@fr, "30484-77-6 (di-HCl)"@en, "Flunarizin"@en, "C11102TO53"@fr, "C11102TO53"@en ;
  skos:inScheme jvr: ;
  dc:modified "2016-05-31"^^xsd:date ;
  skos:broader jvr:-ZSFBN4K6-W ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D005444> ;
  a mesh:Descriptor, skos:Concept ;
  dc:established "1987-01-01"^^xsd:date ;
  skos:prefLabel "Flunarizine"@en, "Flunarizine"@fr ;
  skos:definition "Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy."@en ;
  dc:created "1986-06-16"^^xsd:date .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .